GE Healthcare is taking steps to secure its supply of the substance used in x-rays and CT scans after shortages of iodinated contrast media led to doctors in the U.S. postponing nonemergency tests.
The company said on Thursday that it struck a long-term agreement with Sociedad Quimica y Minera de Chile S.A., a mining company based in Chile, to secure its supply of iodinated contrast media. GE didn’t disclose the terms of the deal, although it added the agreement would support the company’s goal of producing 30 million more patient doses of iodinated contrast media annually by 2025.
